• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

NIH to sponsor 5-year research project for chronic pelvic pain

Article

The National Institute of Diabetes and Digestive and Kidney Diseases, along with several other National Institutes of Health divisions, said it will commit up to $7.5 million per year starting in the summer of 2008 for a 5-year project to study interstitial cystitis/painful bladder syndrome (IC/PBS), chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), and related conditions.

The National Institute of Diabetes and Digestive and Kidney Diseases, along with several other National Institutes of Health divisions, said it will commit up to $7.5 million per year starting in the summer of 2008 for a 5-year project to study interstitial cystitis/painful bladder syndrome (IC/PBS), chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), and related conditions.

The program, called the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network, is designed to advance the understanding of IC/PBS and CP/CPPS.

The MAPP Research Network will conduct multidisciplinary, collaborative, multi-site, basic, translational, and clinical research. An important focus of the network will be investigation of the biologic and behavioral relationships between IC/PBS and CP/CPPS and other frequently related symptom-based conditions.

Related Videos
Gary D. Steinberg, MD, an expert on bladder cancer
Akhil Das, MD, FACS, answers a question during a video interview
Edward M. Schaeffer, MD, PhD, answers a question during a Zoom video interview
Woman talking with doctor | Image Credit: © rocketclips - stock.adobe.com
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Gamal M. Ghoniem, MD, FACS, ABU/FPMRS, gives an answer during a video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.